AAAAAA

   
Results: 1-14 |
Results: 14
CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS
Authors: PHELAN CM BORG A CUNY M CRICHTON DN BALDERSSON T ANDERSEN TI CALIGO MA LIDEREAU R LINDBLOM A SEITZ S KELSELL D HAMANN K RIO P THORLACIUS S PAPP J OLAH E PONDER B BIGNON YJ SCHERNECK S BARKARDOTTIR R BORRESENDALE AL EYFJORD J THEILLET C THOMPSON AM DEVILEE P LARSSON C
Citation: Cm. Phelan et al., CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS, Cancer research, 58(5), 1998, pp. 1004-1012
BRCA1 AND BRCA2 MUTATION SCREENING IN BREAST-CANCER FAMILIES
Authors: PHELAN CM LANCASTER JM GUMBS C DELOSRIOS P ABRAHAMSON J WARNER E PARFREY NA FUTREAL PA NAROD SA
Citation: Cm. Phelan et al., BRCA1 AND BRCA2 MUTATION SCREENING IN BREAST-CANCER FAMILIES, British Journal of Cancer, 78, 1998, pp. 35-35
MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES (VOL 13, PG 120, 1996)
Authors: PHELAN CM LANCASTER JM TONIN P GUMBS C COCHRAN C CARTER R GHADIRIAN P PERRET C MOSLEHI R DION F FAUCHER MC DOLE K KARIMI S FOULKES W LOUNIS H WARNER E GOSS P ANDERSON D LARSSON C NAROD SA FUTREAL PA
Citation: Cm. Phelan et al., MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES (VOL 13, PG 120, 1996), Nature genetics, 13(3), 1996, pp. 374-374
BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS
Authors: LANCASTER JM WOOSTER R MANGION J PHELAN CM COCHRAN C GUMBS C SEAL S BARFOOT R COLLINS N BIGNELL G PATEL S HAMOUDI R LARSSON C WISEMAN RW BERCHUCK A IGLEHART JD MARKS JR ASHWORTH A STRATTON MR FUTREAL PA
Citation: Jm. Lancaster et al., BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS, Nature genetics, 13(2), 1996, pp. 238-240
MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES
Authors: PHELAN CM LANCASTER JM TONIN P GUMBS C COCHRAN C CARTER R GHADIRIAN P PERRET C MOSLEHI R DION F FAUCHER MC DOLE K KARIMI S FOULKES W LOUNIS H WARNER E GOSS P ANDERSON D LARSSON C NAROD SA FUTREAL PA
Citation: Cm. Phelan et al., MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES, Nature genetics, 13(1), 1996, pp. 120-122
OVARIAN-CANCER RISK IN BRCA1 CARRIERS IS MODIFIED BY THE HRAS1 VARIABLE NUMBER OF TANDEM REPEAT (VNTR) LOCUS
Authors: PHELAN CM REBBECK TR WEBER BL DEVILEE P RUTTLEDGE MH LYNCH HT LENOIR GM STRATTON MR EASTON DF PONDER BAJ CANNONALBRIGHT L LARSSON C GOLDGAR DE NAROD SA
Citation: Cm. Phelan et al., OVARIAN-CANCER RISK IN BRCA1 CARRIERS IS MODIFIED BY THE HRAS1 VARIABLE NUMBER OF TANDEM REPEAT (VNTR) LOCUS, Nature genetics, 12(3), 1996, pp. 309-311
THE HUMAN MAMMARY-DERIVED GROWTH INHIBITOR (MDGI) GENE - GENOMIC STRUCTURE AND MUTATION ANALYSIS IN HUMAN BREAST-TUMORS (VOL 34, PG 63, 1996)
Authors: PHELAN CM LARSSON C BAIRD S FUTREAL PA RUTTLEDGE MH MORGAN K TONIN P HUNG H KORNELUK RG POLLAK MN NAROD SA
Citation: Cm. Phelan et al., THE HUMAN MAMMARY-DERIVED GROWTH INHIBITOR (MDGI) GENE - GENOMIC STRUCTURE AND MUTATION ANALYSIS IN HUMAN BREAST-TUMORS (VOL 34, PG 63, 1996), Genomics, 36(2), 1996, pp. 377-377
THE HUMAN MAMMARY-DERIVED GROWTH INHIBITOR (MDGI) GENE - GENOMIC STRUCTURE AND MUTATION ANALYSIS IN HUMAN BREAST-TUMORS
Authors: PHELAN CM LARSSON C BAIRD S FUTREAL PA RUTTLEDGE MH MORGAN K TONIN P HUNG H KORNELUK RG POLLAK MN NAROD SA
Citation: Cm. Phelan et al., THE HUMAN MAMMARY-DERIVED GROWTH INHIBITOR (MDGI) GENE - GENOMIC STRUCTURE AND MUTATION ANALYSIS IN HUMAN BREAST-TUMORS, Genomics, 34(1), 1996, pp. 63-68
TYPE OF MUTATION IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) FREQUENTLY DETERMINES SEVERITY OF DISEASE
Authors: RUTTLEDGE MH ANDERMANN AA PHELAN CM CLAUDIO JO HAN FY CHRETIEN N RANGARATNAM S MACCOLLIN M SHORT P PARRY D MICHELS V RICCARDI VM WEKSBERG R KITAMURA K BRADBURN JM HALL BD PROPPING P ROULEAU GA
Citation: Mh. Ruttledge et al., TYPE OF MUTATION IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) FREQUENTLY DETERMINES SEVERITY OF DISEASE, American journal of human genetics, 59(2), 1996, pp. 331-342
CHROMOSOME-17 ABNORMALITIES AND LACK OF TP53 MUTATIONS IN PEDIATRIC CENTRAL-NERVOUS-SYSTEM TUMORS
Authors: PHELAN CM LIU L RUTTLEDGE MH MUNTZNING K RIDDERHEIM PA COLLINS VP
Citation: Cm. Phelan et al., CHROMOSOME-17 ABNORMALITIES AND LACK OF TP53 MUTATIONS IN PEDIATRIC CENTRAL-NERVOUS-SYSTEM TUMORS, Human genetics, 96(6), 1995, pp. 684-690
HEART RATE-DEPENDENT CHARACTERISTICS OF DIASTOLIC VENTRICULAR FILLINGIN THE DEVELOPING CHICK-EMBRYO
Authors: PHELAN CM HUGHES SF BENSON DW
Citation: Cm. Phelan et al., HEART RATE-DEPENDENT CHARACTERISTICS OF DIASTOLIC VENTRICULAR FILLINGIN THE DEVELOPING CHICK-EMBRYO, Pediatric research, 37(3), 1995, pp. 289-293
GENOMIC STRUCTURE OF HUMAN MAMMARY-DERIVED GROWTH INHIBITOR AND MUTATION ANALYSIS IN SPORADIC HUMAN BREAST-TUMORS
Authors: PHELAN CM BAIRD S LARSSON C FUTREAL PA KORNELUK RG POLLAK MN NAROD SA
Citation: Cm. Phelan et al., GENOMIC STRUCTURE OF HUMAN MAMMARY-DERIVED GROWTH INHIBITOR AND MUTATION ANALYSIS IN SPORADIC HUMAN BREAST-TUMORS, American journal of human genetics, 57(4), 1995, pp. 402-402
EVIDENCE FOR THE COMPLETE INACTIVATION OF THE NF2 GENE IN THE MAJORITY OF SPORADIC MENINGIOMAS
Authors: RUTTLEDGE MH SARRAZIN J RANGARATNAM S PHELAN CM TWIST E MEREL P DELATTRE O THOMAS G NORDENSKJOLD M COLLINS VP DUMANSKI JP ROULEAU GA
Citation: Mh. Ruttledge et al., EVIDENCE FOR THE COMPLETE INACTIVATION OF THE NF2 GENE IN THE MAJORITY OF SPORADIC MENINGIOMAS, Nature genetics, 6(2), 1994, pp. 180-184
AN ANALYSIS OF THE RELATIONSHIP BETWEEN INTRAVENTRICULAR HEMORRHAGE AND RETINOPATHY OF PREMATURITY
Authors: SCHMIDT CH PHELAN CM FOWELL SM KELLY MJ
Citation: Ch. Schmidt et al., AN ANALYSIS OF THE RELATIONSHIP BETWEEN INTRAVENTRICULAR HEMORRHAGE AND RETINOPATHY OF PREMATURITY, Pediatric research, 35(4), 1994, pp. 10000253-10000253
Risultati: 1-14 |